Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387002550> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4387002550 abstract "Limited real-world data on the benefits and risks associated with 3 and 4.5 mg doses of dulaglutide currently exists, making it difficult to determine the impact of dose titration for patients currently managed with dulaglutide 1.5 mg weekly.To determine the impact of dulaglutide 3 and 4.5 mg doses on weight and hemoglobin A1c (HbA1c) in patients with type 2 diabetes mellitus (T2DM), in clinical practice.Retrospective, observational study of adult T2DM patients receiving dulaglutide 3 or 4.5 mg weekly within a large, university-affiliated, primary care network. The primary outcome was change in weight and HbA1c from baseline to 24 weeks. Secondary outcomes included incremental changes in weight and HbA1c, and describing trends related to dose reductions.Ninety-five patients were included, 62 in the dulaglutide 3 mg group and 33 in the dulaglutide 4.5 mg group. After 24 weeks, the mean changes in weight and HbA1c from baseline were -1.8 kg (P < 0.01) and -0.4% (P < 0.01) in the 3 mg group, and -4.2 kg (P < 0.01) and -0.4% (P = 0.119) in the 4.5 mg group. Incremental change in weight and HbA1c among patients who were titrated from dulaglutide 3 to 4.5 mg weekly were -2.6 kg (P < 0.01) and -0.2% (P = 0.04), respectively.Titration from dulaglutide 1.5 to 3 mg resulted in significant reductions in weight and HbA1c after 24 weeks. Additional, statistically significant, reductions in weight and HbA1c were seen when patients were further titrated to dulaglutide 4.5 mg weekly." @default.
- W4387002550 created "2023-09-26" @default.
- W4387002550 creator A5020958579 @default.
- W4387002550 creator A5048317694 @default.
- W4387002550 creator A5061817508 @default.
- W4387002550 creator A5074600227 @default.
- W4387002550 creator A5082992272 @default.
- W4387002550 creator A5092932540 @default.
- W4387002550 date "2023-09-24" @default.
- W4387002550 modified "2023-10-01" @default.
- W4387002550 title "Real-world Impact of 3 and 4.5 mg Doses of Dulaglutide on Weight and Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus" @default.
- W4387002550 cites W2093274439 @default.
- W4387002550 cites W2108430483 @default.
- W4387002550 cites W2140564842 @default.
- W4387002550 cites W2514766623 @default.
- W4387002550 cites W2948612418 @default.
- W4387002550 cites W3005269555 @default.
- W4387002550 cites W3119307884 @default.
- W4387002550 cites W3174970167 @default.
- W4387002550 cites W3185437491 @default.
- W4387002550 cites W4311182596 @default.
- W4387002550 cites W4311263985 @default.
- W4387002550 cites W4311264067 @default.
- W4387002550 doi "https://doi.org/10.1177/10600280231199852" @default.
- W4387002550 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37743669" @default.
- W4387002550 hasPublicationYear "2023" @default.
- W4387002550 type Work @default.
- W4387002550 citedByCount "0" @default.
- W4387002550 crossrefType "journal-article" @default.
- W4387002550 hasAuthorship W4387002550A5020958579 @default.
- W4387002550 hasAuthorship W4387002550A5048317694 @default.
- W4387002550 hasAuthorship W4387002550A5061817508 @default.
- W4387002550 hasAuthorship W4387002550A5074600227 @default.
- W4387002550 hasAuthorship W4387002550A5082992272 @default.
- W4387002550 hasAuthorship W4387002550A5092932540 @default.
- W4387002550 hasConcept C126322002 @default.
- W4387002550 hasConcept C134018914 @default.
- W4387002550 hasConcept C2777180221 @default.
- W4387002550 hasConcept C2778917026 @default.
- W4387002550 hasConcept C2779829264 @default.
- W4387002550 hasConcept C2780533449 @default.
- W4387002550 hasConcept C2910068830 @default.
- W4387002550 hasConcept C3017894415 @default.
- W4387002550 hasConcept C511355011 @default.
- W4387002550 hasConcept C544821477 @default.
- W4387002550 hasConcept C555293320 @default.
- W4387002550 hasConcept C71924100 @default.
- W4387002550 hasConcept C90924648 @default.
- W4387002550 hasConceptScore W4387002550C126322002 @default.
- W4387002550 hasConceptScore W4387002550C134018914 @default.
- W4387002550 hasConceptScore W4387002550C2777180221 @default.
- W4387002550 hasConceptScore W4387002550C2778917026 @default.
- W4387002550 hasConceptScore W4387002550C2779829264 @default.
- W4387002550 hasConceptScore W4387002550C2780533449 @default.
- W4387002550 hasConceptScore W4387002550C2910068830 @default.
- W4387002550 hasConceptScore W4387002550C3017894415 @default.
- W4387002550 hasConceptScore W4387002550C511355011 @default.
- W4387002550 hasConceptScore W4387002550C544821477 @default.
- W4387002550 hasConceptScore W4387002550C555293320 @default.
- W4387002550 hasConceptScore W4387002550C71924100 @default.
- W4387002550 hasConceptScore W4387002550C90924648 @default.
- W4387002550 hasLocation W43870025501 @default.
- W4387002550 hasLocation W43870025502 @default.
- W4387002550 hasOpenAccess W4387002550 @default.
- W4387002550 hasPrimaryLocation W43870025501 @default.
- W4387002550 hasRelatedWork W1482540465 @default.
- W4387002550 hasRelatedWork W2043111603 @default.
- W4387002550 hasRelatedWork W2139452290 @default.
- W4387002550 hasRelatedWork W2914021057 @default.
- W4387002550 hasRelatedWork W3174970167 @default.
- W4387002550 hasRelatedWork W4205820411 @default.
- W4387002550 hasRelatedWork W4243738937 @default.
- W4387002550 hasRelatedWork W4312070346 @default.
- W4387002550 hasRelatedWork W4381337748 @default.
- W4387002550 hasRelatedWork W4381737345 @default.
- W4387002550 isParatext "false" @default.
- W4387002550 isRetracted "false" @default.
- W4387002550 workType "article" @default.